Clearmind Medicine, Inc. (CMND)
0.715
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
0.71
0.00 (0.00%)
After-Hours: 20:00
Clearmind Medicine Cash from Operations (TTM) : -6.997M for July 31, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| July 31, 2026 | -6.997M |
| April 30, 2026 | -6.292M |
| January 31, 2026 | -5.597M |
| October 31, 2025 | -4.778M |
| July 31, 2025 | -4.603M |
| April 30, 2025 | -4.557M |
| January 31, 2025 | -4.647M |
| October 31, 2024 | -4.843M |
| July 31, 2024 | -4.413M |
| April 30, 2024 | -4.747M |
| January 31, 2024 | -4.618M |
| October 31, 2023 | -6.260M |
| July 31, 2023 | -5.696M |
| April 30, 2023 | -4.490M |
| January 31, 2023 | -5.528M |
| October 31, 2022 | -3.835M |
| Date | Value |
|---|---|
| July 31, 2022 | -5.127M |
| April 30, 2022 | -5.247M |
| January 31, 2022 | -3.594M |
| October 31, 2021 | -2.255M |
| July 31, 2021 | -0.9351M |
| April 30, 2021 | -0.639M |
| January 31, 2021 | -0.2728M |
| October 31, 2020 | -0.20M |
| July 31, 2020 | -0.1472M |
| April 30, 2020 | -0.1015M |
| January 31, 2020 | -0.0266M |
| October 31, 2019 | -0.0476M |
| July 31, 2019 | -0.0806M |
| April 30, 2019 | -0.0712M |
| January 31, 2019 | -0.0814M |
| October 31, 2018 | -0.0811M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| InMed Pharmaceuticals, Inc. | -8.628M |
| NervGen Pharma Corp. | -18.43M |
| Milestone Pharmaceuticals, Inc. | -60.75M |
| Lexaria Bioscience Corp. | -7.426M |
| Target Group, Inc. (Canada) | -1.073M |